65 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
the extraction of as few as 20 hair follicles from the back of a patient's scalp via a single punch biopsy. NBDS cells are isolated from the hair … the desired result and the patient is limited by the number of hairs that can be redistributed. In contrast, RCH-01 involves the extraction of as few as 20
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
was randomized, double-blinded, placebo-controlled with a treatment-to-placebo ration of 3:1. The mechanics of the Company's treatment involve the extraction … and the patient is limited by the number of hairs that can be redistributed. In contrast, RCH-01 involves the extraction of as few as 20 hair follicles from
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
-to-placebo ration of 3:1. The mechanics of the Company's treatment involve the extraction of as few as 20 hair follicles from the back of a patient's … result and the patient is limited by the number of hairs that can be redistributed. In contrast, RCH-01 involves the extraction of as few as 20 hair
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
the extraction of as few as 20 hair follicles from the back of a patient’s scalp via a single punch biopsy. NBDS cells are isolated from the hair follicle … the desired result and the patient is limited by the number of hairs that can be redistributed. In contrast, RCH-01 involves the extraction of as few as 20 hair
20-F/A
ldupwnyo9l7l0de
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
4s1he8k csj8xkgd
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.4
eimzximxka
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.2
fizhs
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
q9fm5l
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
6g5v1t26mb5v
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
u891c5aavyuxvmb74b1b
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.3
dtzf3p l1l15pcp3
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
vkrm flj2k751r67q
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.2
3axqo5jq17zn
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm
6-K
EX-99.2
5q2lnk6
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.2
3m41rbj68 kwsi8
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm